| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
27,658 |
17,095 |
$2.73M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,149 |
21,481 |
$1.09M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,075 |
14,415 |
$1.01M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,863 |
4,327 |
$507K |
| 90834 |
Psychotherapy, 45 minutes with patient |
11,804 |
6,025 |
$495K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,237 |
3,253 |
$484K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
2,258 |
1,571 |
$273K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
529 |
234 |
$257K |
| A0425 |
Ground mileage, per statute mile |
6,010 |
3,748 |
$220K |
| 99215 |
Prolong outpt/office vis |
1,759 |
1,096 |
$108K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
590 |
467 |
$99K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,286 |
1,093 |
$82K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,654 |
632 |
$81K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,406 |
948 |
$49K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,170 |
991 |
$44K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,140 |
7,730 |
$37K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
444 |
331 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
221 |
176 |
$34K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
728 |
570 |
$33K |
| 90791 |
Psychiatric diagnostic evaluation |
412 |
359 |
$31K |
| 71046 |
Radiologic examination, chest; 2 views |
200 |
183 |
$26K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,748 |
4,107 |
$26K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
320 |
240 |
$25K |
| 80053 |
Comprehensive metabolic panel |
4,967 |
3,936 |
$23K |
| 20553 |
|
922 |
521 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
659 |
615 |
$21K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
203 |
156 |
$20K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,005 |
1,676 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
11,518 |
9,049 |
$17K |
| 20610 |
|
847 |
455 |
$17K |
| 80050 |
General health panel |
89 |
81 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
178 |
152 |
$15K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
756 |
609 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
139 |
122 |
$13K |
| 99205 |
Prolong outpt/office vis |
108 |
80 |
$11K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
45 |
12 |
$8K |
| 90837 |
Psychotherapy, 53 minutes with patient |
58 |
45 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
469 |
438 |
$7K |
| 59425 |
|
152 |
92 |
$7K |
| 83605 |
|
957 |
621 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
62 |
57 |
$5K |
| 80061 |
Lipid panel |
824 |
754 |
$5K |
| 94060 |
|
191 |
124 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
372 |
343 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
367 |
288 |
$5K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
64 |
48 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,064 |
896 |
$4K |
| 90688 |
|
451 |
349 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
107 |
67 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
476 |
267 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
601 |
545 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
966 |
770 |
$2K |
| 81001 |
|
1,343 |
1,005 |
$2K |
| 59426 |
|
23 |
13 |
$2K |
| 81003 |
|
1,339 |
862 |
$2K |
| 86140 |
|
488 |
354 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
230 |
202 |
$2K |
| 84484 |
|
302 |
175 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
75 |
52 |
$1K |
| 93000 |
|
37 |
25 |
$1K |
| 83735 |
|
302 |
233 |
$1K |
| 84439 |
|
171 |
159 |
$1K |
| 90686 |
|
312 |
247 |
$1K |
| 99442 |
|
88 |
50 |
$1K |
| 97162 |
|
29 |
27 |
$948.79 |
| 87634 |
|
14 |
13 |
$912.60 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
443 |
266 |
$874.23 |
| 83721 |
|
124 |
111 |
$837.32 |
| 84145 |
|
128 |
93 |
$726.10 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12 |
12 |
$708.85 |
| 99222 |
Initial hospital care, per day, moderate complexity |
21 |
12 |
$708.49 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
883 |
621 |
$595.09 |
| 94726 |
|
82 |
54 |
$438.91 |
| 90670 |
|
104 |
82 |
$405.23 |
| 83655 |
|
33 |
26 |
$379.21 |
| 94729 |
|
80 |
52 |
$315.82 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
60 |
30 |
$285.35 |
| 82553 |
|
136 |
89 |
$281.77 |
| 83690 |
|
75 |
64 |
$265.96 |
| 82550 |
|
139 |
91 |
$250.27 |
| 83880 |
|
13 |
12 |
$198.31 |
| 85027 |
|
43 |
41 |
$197.64 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
13 |
$170.10 |
| 87420 |
|
15 |
13 |
$157.18 |
| 87807 |
|
15 |
13 |
$153.45 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
17 |
12 |
$147.42 |
| 84703 |
|
19 |
12 |
$130.10 |
| 80051 |
|
124 |
107 |
$128.13 |
| 82565 |
|
131 |
120 |
$111.49 |
| J3490 |
Unclassified drugs |
31 |
12 |
$85.52 |
| 84520 |
|
116 |
105 |
$81.72 |
| 80076 |
|
14 |
13 |
$81.70 |
| 90723 |
|
41 |
29 |
$81.55 |
| 82010 |
|
13 |
12 |
$53.40 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
860 |
491 |
$48.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
42 |
39 |
$46.47 |
| 82150 |
|
30 |
25 |
$29.66 |
| 82248 |
|
14 |
13 |
$22.20 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
52 |
14 |
$20.19 |
| 90648 |
|
82 |
66 |
$10.93 |
| 81025 |
|
23 |
13 |
$9.24 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
147 |
99 |
$8.81 |
| J2704 |
Injection, propofol, 10 mg |
722 |
254 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
203 |
123 |
$0.00 |
| M1207 |
Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety |
353 |
315 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
68 |
40 |
$0.00 |
| 88342 |
|
40 |
25 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
30 |
27 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
47 |
38 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
51 |
48 |
$0.00 |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
21 |
14 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,193 |
937 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
419 |
289 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
49 |
24 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
53 |
47 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |